EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis

Early and irreversible recurrence MPO-ANCA-positive glomerulonephritis after renal transplantation

(2015) Ludmilla Le Berre et al.   CLINICAL NEPHROLOGY

Randomized trial investigating the safety and efficacy of influenza vaccination in patients with antineutrophil cytoplasmic antibody-associated vasculitis

(2015) Lisa S Jeffs et al.   NEPHROLOGY

Outcomes of Nonsevere Relapses in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Treated With Glucocorticoids

(2015) E. M. Miloslavsky et al.   Arthritis & Rheumatology

Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg–Strauss)

(2014) A J Mohammad et al.   ANNALS OF THE RHEUMATIC DISEASES

The New Histopathologic Classification of ANCA-Associated GN and Its Association with Renal Outcomes in Childhood

(2014) D. G. Noone et al.   Clinical Journal of the American Society of Nephrology

A Population-based Study Showing Better Renal Prognosis for Proteinase 3 Antineutrophil Cytoplasmic Antibody (ANCA)-associated Nephritis Versus Myeloperoxidase ANCA-associated Nephritis

(2014) A. J. Mohammad et al.   JOURNAL OF RHEUMATOLOGY

Granulomatosis With Polyangiitis (Wegener’s)

(2014) Jason Springer et al.   MEDICINE

Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis

(2014) Loïc Guillevin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis

(2014) Federico Alberici et al.   RHEUMATOLOGY

Markers for work disability in anti-neutrophil cytoplasmic antibody-associated vasculitis

(2014) N. Basu et al.   RHEUMATOLOGY

Renal function and ear, nose, throat involvement in anti-neutrophil cytoplasmic antibody-associated vasculitis: prospective data from the European Vasculitis Society clinical trials

(2014) Chinar Rahmattulla et al.   RHEUMATOLOGY

The informational needs of patients with ANCA-associated vasculitis--development of an informational needs questionnaire

(2014) J. Mooney et al.   RHEUMATOLOGY

Histopathologic and Clinical Predictors of Kidney Outcomes in ANCA-Associated Vasculitis

(2013) Sharon L. Ford et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Pulse Versus Daily Oral Cyclophosphamide for Induction of Remission in Antineutrophil Cytoplasmic Antibody—Associated Vasculitis

(2013) Kirsten de Groot   ANNALS OF INTERNAL MEDICINE

The characterisation and determinants of quality of life in ANCA associated vasculitis

(2013) Neil Basu et al.   ANNALS OF THE RHEUMATIC DISEASES

Damage in the anca-associated vasculitides: long-term data from the European Vasculitis Study group (EUVAS) therapeutic trials

(2013) Joanna Robson et al.   ANNALS OF THE RHEUMATIC DISEASES

Clinical Outcomes of Remission Induction Therapy for Severe Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

(2013) E. M. Miloslavsky et al.   ARTHRITIS AND RHEUMATISM

Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear

(2013) Michael Walsh et al.   KIDNEY INTERNATIONAL

Does geographic location affect incidence of ANCA-associated renal vasculitis in northern Saskatchewan, Canada?

(2013) Keltie Anderson et al.   RHEUMATOLOGY

Orbital masses in granulomatosis with polyangiitis are associated with a refractory course and a high burden of local damage

(2013) Julia U. Holle et al.   RHEUMATOLOGY

Explaining fatigue in ANCA-associated vasculitis

(2013) N. Basu et al.   RHEUMATOLOGY

Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial

(2013) Michael Walsh et al.   Trials

Bleeding Complications of Native Kidney Biopsy: A Systematic Review and Meta-analysis

(2012) Kristin M. Corapi et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg–Strauss, EGPA): monocentric experiences in 150 patients

(2012) Frank Moosig et al.   ANNALS OF THE RHEUMATIC DISEASES

Brief Report: Long-term outcome of a randomized clinical trial comparing methotrexate to cyclophosphamide for remission induction in early systemic antineutrophil cytoplasmic antibody-associated vasculitis

(2012) Mikkel Faurschou et al.   ARTHRITIS AND RHEUMATISM

2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

(2012) J. C. Jennette et al.   ARTHRITIS AND RHEUMATISM

Pulmonary involvement in ANCA-associated vasculitis from the view of the pulmonologist

(2012) Sakae Homma et al.   Clinical and Experimental Nephrology

Effect of delayed diagnosis on disease course and management of Churg–Strauss syndrome: a retrospective study

(2012) Barbara Sokołowska et al.   CLINICAL RHEUMATOLOGY

Impact of Rituximab on Immunoglobulin Concentrations and B Cell Numbers after Cyclophosphamide Treatment in Patients with ANCA-Associated Vasculitides

(2012) Nils Venhoff et al.   PLoS One

Off-Trial Evaluation of the B cell-Targeting Treatment in the Refractory Cases of Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis: Long-Term Follow-Up from a Single Centre

(2012) R. Pullerits et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Effects of Mycophenolate Mofetil Combined with Corticosteroids for Induction Therapy of Microscopic Polyangiitis

(2011) Fei Han et al.   AMERICAN JOURNAL OF NEPHROLOGY

Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up

(2011) Lorraine Harper et al.   ANNALS OF THE RHEUMATIC DISEASES

Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis

(2011) Michael Walsh et al.   ARTHRITIS AND RHEUMATISM

Tubular Lesions Predict Renal Outcome in Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis after Rituximab Therapy

(2011) A. E. Berden et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Prolonged disease-free remission following rituximab and low-dose cyclophosphamide therapy for renal ANCA-associated vasculitis

(2011) N. Mansfield et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Rituximab for the treatment of Churg-Strauss syndrome with renal involvement

(2011) R. Cartin-Ceba et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Re-evaluation of the histopathologic classification of ANCA-associated glomerulonephritis: a study of 121 patients in a single center

(2011) D.-y. Chang et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis--a meta-analysis

(2011) G. Tomasson et al.   RHEUMATOLOGY

Epidemiology and Etiology of Wegener Granulomatosis, Microscopic Polyangiitis, Churg-Strauss Syndrome and Goodpasture Syndrome: Vasculitides with Frequent Lung Involvement

(2011) Aude Gibelin et al.   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis

(2011) Michael Walsh et al.   ARTHRITIS CARE & RESEARCH

Ovarian reserve diminished by oral cyclophosphamide therapy for granulomatosis with polyangiitis (Wegener's)

(2011) Megan E. B. Clowse et al.   ARTHRITIS CARE & RESEARCH

A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis

(2011) Ravi Suppiah et al.   ARTHRITIS CARE & RESEARCH

Plasma Exchange for Renal Vasculitis and Idiopathic Rapidly Progressive Glomerulonephritis: A Meta-analysis

(2010) Michael Walsh et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Treatment strategies and outcome of induction-refractory Wegener's granulomatosis or microscopic polyangiitis: analysis of 32 patients with first-line induction-refractory disease in the WEGENT trial

(2010) R. Seror et al.   ANNALS OF THE RHEUMATIC DISEASES

EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

(2010) S. van Assen et al.   ANNALS OF THE RHEUMATIC DISEASES

Long-term patient survival in ANCA-associated vasculitis

(2010) O. Flossmann et al.   ANNALS OF THE RHEUMATIC DISEASES

Mycophenolate Mofetil vs Azathioprine for Remission Maintenance in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

(2010) Thomas F. Hiemstra et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Histopathologic Classification of ANCA-Associated Glomerulonephritis

(2010) A. E. Berden et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Plasma exchange for induction and cyclosporine A for maintenance of remission in Wegener's granulomatosis--a clinical randomized controlled trial

(2010) W. M. Szpirt et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

(2010) John H. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

(2010) Rachel B. Jones et al.   NEW ENGLAND JOURNAL OF MEDICINE

Gonadal Failure with Cyclophosphamide Therapy for Lupus Nephritis: Advances in Fertility Preservation

(2010) Jennifer Mersereau et al.   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

Fatigue: a principal contributor to impaired quality of life in ANCA-associated vasculitis

(2010) N. Basu et al.   RHEUMATOLOGY

A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis

(2010) R. Suppiah et al.   RHEUMATOLOGY

Effects of duration of glucocorticoid therapy on relapse rate in antineutrophil cytoplasmic antibody-associated vasculitis: A meta-analysis

(2010) Michael Walsh et al.   ARTHRITIS CARE & RESEARCH

Patient-reported outcome assessment in vasculitis may provide important data and a unique perspective

(2010) Karen Herlyn et al.   ARTHRITIS CARE & RESEARCH

Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis

(2009) M. A. Little et al.   ANNALS OF THE RHEUMATIC DISEASES

Prevalence and incidence of Wegener's granulomatosis in the UK general practice research database

(2009) Richard A. Watts et al.   ARTHRITIS AND RHEUMATISM

Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: A data-driven review

(2009) Paul A. Monach et al.   ARTHRITIS AND RHEUMATISM

Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa

(2009) A. J. Mohammad et al.   RHEUMATOLOGY

Wegener's granulomatosis patients show an adequate antibody response to influenza vaccination

(2008) A Holvast et al.   ANNALS OF THE RHEUMATIC DISEASES

Modification and validation of the Birmingham Vasculitis Activity Score (version 3)

(2008) C Mukhtyar et al.   ANNALS OF THE RHEUMATIC DISEASES

Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis

(2008) P A Merkel et al.   ANNALS OF THE RHEUMATIC DISEASES

EULAR recommendations for the management of primary small and medium vessel vasculitis

(2008) C Mukhtyar et al.   ANNALS OF THE RHEUMATIC DISEASES

Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: Comparison of two independent cohorts

(2008) Christian Pagnoux et al.   ARTHRITIS AND RHEUMATISM

Epidemiology of primary systemic vasculitis in the Australian Capital Territory and south-eastern New South Wales

(2008) A. S. Ormerod et al.   INTERNAL MEDICINE JOURNAL

Wegener's granulomatosis in Finland in 1981–2000: clinical presentation and diagnostic delay

(2008) J. H. Takala et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Longitudinale Effekte des strukturierten Patientenschulungsprogramms für Vaskulitispatienten

(2008) K. Herlyn et al.   ZEITSCHRIFT FUR RHEUMATOLOGIE